Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer

NCT02985658 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
Triple-Negative Breast Cancer

Interventions

DRUG: Veliparib
DRUG: Cisplatin
DRUG: Vinorelbine

Sponsor

University of Washington

Collaborators

[object Object]